DS Healthcare Group Issues Letter to Shareholders Pompano

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DS Healthcare Group Issues Letter to Shareholders

Pompano Beach, Fla., Nov. 14, 2014 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ: DSKX ), a leading developer of personal care and specialty pharmaceutical products, today issued the following letter to shareholders:

Dear Fellow Shareholder,

Like you, I have been watching the screen in disappointment as our stock has made a continuous decline to record lows. So everyone is wondering, what's going on? It's time to set the record straight.

We are getting calls from shareholders who are saying things like "what are you not telling me? There is no way that the stock would decline so quickly unless something is wrong". It is clear that there is a lot of confusion and now panic. As some shareholders are only watching the chart and otherwise have no other information, it is easy to assume the worst.

If you take a moment to consider the facts it should be obvious that at these prices our stock is spectacularly undervalued. For the first time in history, our market capitalization has dropped below our annual revenue levels. As of the time of this writing our market capitalization is $11.4m while last year's revenue was $13.7m with even more revenue expected this year, with 6 consecutive years of revenue increases. Our total assets as of September 30 th , 2014 were $7.9m. Considering only our cosmetic products business, competitors in our space typically see valuations that are several times revenue. Our negative earnings which were mainly the result of lower than normal industry product margins were caused by: 1.) The company's unwavering commitment to manufacture and distribute the most cutting edge and highest quality products, which in turn have built strong relationships with our customers and 2.) Inefficiencies in our infrastructure and supply chain.   

However, I believe the value of what we have built is many times greater than the negative earning seen in the last few years. The company has established a network of dedicated domestic and international distributors in over a dozen countries and many of them depend on DS Healthcare for a significant portion of their annual revenue and income. Because we sell our products primarily through a distribution model - to distributor who in turn sells to retailer and retailer to consumer - last year's revenue of $13.7m from distribution translates into approximately $55m spent on DS Healthcare products last year by consumers. What is the current and future value of this distribution network alone, putting the value of everything else aside?

There are three primary mechanisms of growth in our consumer products business:

-       Increasing the size of our distribution network by continuously adding new distributors and key retailers. Quite simply, having the product on more shelves creates more revenue.

-       Providing dedicated support to existing distributors through education, training, and marketing programs. An example of such a program might be running a promotional offer where any customer who buys a particular product gets a free sample of some other product. Or having regular meetings with distributors' staff and providing education, training, and exciting offers.

-       Continuously introducing innovative new products through existing and growing distribution. Quite simply, having more products that people want on existing shelves creates more revenue.

We have been making steady progress and significant strides in all three of these mechanisms. In particular, serious effort went into support of existing relationships because we learned that growing the size of our distribution is easy (new regions and retailers want our products because they are innovative and have almost no direct competitors) but supporting our distribution has been difficult which lead to some underperforming and failing distributors (no matter how good your product is, merely placing it on a shelf and doing nothing else is a recipe for failure). This year our team has refocused their efforts on our infrastructure, communication, and management of many key accounts. Since many of these accounts are only at a small fraction of their potential, working with and supporting our distribution partners will have a dramatic increase in sales in those regions.

And as I have always said, DS Healthcare represents a fundamentally stable and resilient business. If you take away any of the exciting upside, DS Healthcare is here to stay. Our current business can be viewed as follows:

-       Proprietary products and technologies, with strong branding (no "me-too" products that are just like competitors, this is pretty obvious)

-       Diversified customer base

-       Relatively few competitors within our space and healthy market share

-       Diversified products - no one product more than 20-25% of sales

-       Diversified regions - company sells in over a dozen countries which lowers our regulatory risk (every country has its own regulations for personal care products)

-       Many possibilities of reducing manufacturing and overhead costs

-       Stable and growing revenue since inception (no year has been down from the one before with 39% average year over year growth over 6 years)

-       Our consumer products are relatively recession proof with an average retail price of $35

We are also rapidly advancing towards profitability which can be considered the main issue raised by shareholders. Our operations have become more efficient and streamlined this year. Under new management in charge of our supply chain and we have fewer mistakes in production and better planning. This has resulted in fewer rush charges (things like air shipping of materials instead of ground), fewer mistakes, and virtually no back orders which have previously affected repeat order volume from customers. With better supply chain management we are now seeing better margins. These efficiencies have also extended to other parts of the company.

If today's stock price were any indicator of our business results, I can see how some of you might think the company is in trouble. However, the fact remains that as of this moment we have never been in a better position with our business and our prospects have never been as positive. In the first 5 weeks of the current quarter the company has already received in excess of $2.8m in purchases. In my opinion, these are good results that indicate that we are headed in the right direction.

Our working capital needs are fully met to maintain our operations and to execute our business model. Working capital has increased considerably from last quarter and I am pleased to report that our long-term debt has been reduced to zero.

I wanted you to get a feel for what is happening within our distribution network so we asked a few of our major distributors for their comments. Here is what they are saying (I included all comments, not just ones that I thought sounded nice):

" DS Laboratories has been a brand that has shown fantastic growth within our market since launching in March of 2012. Their products stand alone in multiple categories. We are excited for the upcoming fiscal year 2015 to be able to launch out their new programs, which include new marketing, in-depth education and rewards plans for our staff and our salon base. These new programs will ensure large growth for 2015 and beyond. The vision for DS Laboratories branding and programs has our team excited for the future with this great brand ." Ro Lal, Sales Director, West Coast Beauty

  www.west-coast-beauty.com

" Following our last planning meeting, I wanted to reach out to share the excitement and confidence that I am feeling about the upcoming year with DS Labs. I have seen nothing but positive momentum since we launched the Hair care line in January of 2014. With the new rewards program and educational support etc, I am confident that we have covered all the elements of the strategic plan to execute and achieve our mutually desired sales objectives in 2015. In addition, I am extremely excited to launch the skin care portion of the line with my team. Keep up the good work! I appreciate the partnership and know that the best is to come in 2015 !" Craig Barton, Sr. Vice President of Sales, CanRad Beauty www.CanRad.com

" I am writing this email to tell you that the DS Laboratories brand has been an important addition to the brands that we offer to our customers at Beauty Craft. The brand is unique within the beauty industry with unique formulas and marketing. Beauty Craft and DS Laboratories have partnered for several years and look forward to many more years together. We are excited for the future with innovative programs and products that are helping our customers provide solutions for their customers and in turn result in increased purchases from Beauty Craft. The best part is that consumers who use DS Laboratories continue to buy the products ." Max Wexler, President, Beauty Craft, http://beautycraft.com/

" Premier has been a DS Labs Distributor for the past 3 years. We have watched the brand develop in the Professional Beauty Industry as the potential market leader in it's category.  Of recent, we have seen a new management team that is working diligently to take DS Labs to the next level.  With this has come changes to its marketing and education strategy, of which will better adapt to our industry and lead to future growth ."   Steve Cohen, President, Premier Beauty www.premierbeautysupply.com

" DS has been a great partner brand for Paramount for one simple reason - DS  products deliver results and exceed customer expectations ." Jeff Hagler, CEO, Paramount Beauty www.ParamountBeauty.com

" I have taken time to reflect upon your strategic plan moving forward into 2015. The three areas you have chosen to focus on will most certainly give us the strength to grow sales and market share. I am most interested in the "industry first" reward program DS labs is implementing. This type of innovative thinking will give the brand as much unique positioning in the market place as the fabulous proprietary formulations. I look forward to the branding refinement to continue on the path you started this year. The development of local market educators and or brand managers will give a great daily focus to the brand. When you add these initiatives to the logistic improvements already made this year by DS labs, I anticipate a great year ahead for us both. We look forward to a long and prosperous partnership." Graham Kenny, Director of Sales, International Beauty Services www.InternationalBeauty.ca

Under the leadership of Dr. Brijesh Patel, PhD, our head of research and development, we are not only developing better products which will begin shipping in the near future but many important advances in technology which will certainly be part of revenue creation in the future. These are products and technologies that not only improve efficacy but also sensory feel and more targeted use of costly ingredients.

A new branding initiative is also on the way. Our brand is recognized by consumers as a technology and science oriented innovator of personal care products. However, it has been a double edge sword that has alienated some consumers. We are currently perceived as a solution that you turn to when you have a problem but not necessarily as a part of daily, healthy lifestyle. For instance, in the professional beauty industry, women represent the bulk of spending and revenue. We think that by combining technology and beauty in our marketing will reposition our products as the ultimate hair care solution to women and that technology leads to better cosmetic results. So by appealing to the female customer base and not just the male customer we can have a large increase in revenue in the channel where women are the predominant shopper. The market for cosmetic shampoos is enormous and products like Revita deliver far better cosmetic results because it works on the scalp rather than just the hair. You will see images from our new branding effort appear on our website shortly.

But everything I have been describing until now just represents our consumer goods business, the value of which I believe exceeds the current marketing capitalization and stock price. What about the other components of our business? It appears that our business model is poorly understood and I will try to clarify it here. Many technology oriented companies have no revenue at all, yet many of them have market capitalization far greater than ours mainly driven on investor speculation. Well, this speculation or any of the value of our other projects is not priced into our stock. What would DS Healthcare look like if it had no consumer goods business and revenue? What would we be worth?

What is the value of pioneering projects like the opening of our hair recovery clinic in Coral Gables, Florida? It is one of a kind medical center where patients can get completely customized solutions for their hair loss and will utilize the latest advances in hair loss therapy most of which are completely unknown to the average physician or dermatologist and are the culmination of years of our research. We can achieve spectacular results for most patients, in most cases a complete full head of hair.

What is the value of attracting the attention of a Fortune 100 company (whose name they asked us not to disclose publically) who approached us for the development of a topical OTC hair loss product for massive distribution? What is the value of this cooperation? How much revenue can it generate in the future and how many other companies of similar size may want our technology for their products? What is the value of those contracts?

How about the value of two newly developed potent drugs (with patents filed) for the treatment for hair loss that could form the basis of a New Drug Application with the FDA? What would be the value of approval of a highly effective topical drug if the only current option on the market for patients is Propecia?

And it seems that few have noticed other important milestones like the approval of therapeutic level 2 treatments granted in Brazil. Many have tried and failed due to Brazil's complex regulatory environment. The Brazilian government has approved the use of the following claims on our packages:

• 95% experienced reduced hair loss.

• 90% experienced hair strengthening.

• 75% experienced faster hair regrowth.

What is the value of such an approval? This alone could be worth more than our entire current market capitalization.

The list goes on. What is the value of the DS Laboratories brand and trademarks? What are our trademarks worth without any other assets attached? In a brand valuation performed by the Great American Group Advisory & Valuation Services, LLC (this was required by our lender which secured a part of the credit facility with our trademarks) conducted in March, 2013 found that the DS brand had a value of $5.14m, when it was worth less than it is now.

How much is DS Healthcare really worth? I couldn't say for sure but certainly many times more than where our stock is today. Raghuram Selvaraju, a respected biotech analyst with Aegis Capital gave DS Healthcare a target price of $5.50 per share (the target date would be right around the time of this letter) after thorough analysis of our fundamentals. This was completely unpaid, independent research.

This is not to say that we don't have our share of challenges, obstacles, and problems. In fact, it is not possible to have a growing business in the consumer goods sector without these challenges. But we have the drive and the determination to overcome them as we have been and overall our situation is full of exciting prospects for our shareholders.

I realize that there is a lot to take in and I will be personally available to each of you to discuss whatever questions or concerns you may have. You can call me directly on 347-276-2598 or email at Daniel@dskx.biz .

I hope that those of you who fear that something is wrong can see that our stock is simply undervalued and if anything presents a unique opportunity to become a shareholder or increase your position at the lowest price ever seen. In the words of the legendary Buffett  "Be Fearful When Others Are Greedy and Greedy When Others Are Fearful" and this has never been truer than it is today, especially when others are fearful for the wrong reasons.

Sincerely,

Daniel Khesin

Chief Executive Officer

Daniel Khesin Chief Investment Officer 347-276-2598

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AWK Adds Fayette Water System With $9M Upgrade Plan

Updated Category News Views 89

Small water systems do not usually collapse in one dramatic heap; they get worn down by scattered pipes, compliance demands, thin staffing and bills nobody wants to raise. That is the backdrop for Pennsylvania American Water’s completed $32.8 million purchase of the Indian Creek Valley Water Authority system. For American Water shareholders, this is the familiar...

Continue Reading
Yoodli's No. 9 Ranking Signals Enterprise AI Traction

Updated Category News Views 96

Ninth place can be easy to dismiss until you notice the company is sitting near the top of a 500-name growth list. Yoodli's No. 9 position on Deloitte's 2026 Technology Fast 500 is a meaningful signal that its AI-based coaching and workforce-skills pitch is getting traction inside large organizations. It is not a revenue disclosure, it is not a valuation marker, and...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 150

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
Disney Springs Hotel Rates Test Holiday Demand Depth

Updated Category News Views 161

A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...

Continue Reading
Frosty Animatronics Put Nostalgia on Lowe's Shelves

Updated Category News Views 114

A moving corncob pipe is not anybody's idea of a macroeconomic signal, yet holiday aisles are built on precisely these little jolts of recognition. Gemmy has teamed with Warner Bros. Discovery Global Consumer Products to place a new animated Frosty the Snowman collection exclusively at Lowe's for the 2026 holiday season. It is cheerful retail business, not earthshaking...

Continue Reading
The Hanover Survey Puts Small-Business Trust on Trial

Updated Category News Views 91

A dark storefront can apparently erase goodwill faster than plenty of owners want to admit. The Hanover Insurance Group's 2026 Small Business Pulse Report found that 60% of surveyed consumers would temporarily buy from a competitor if their preferred small business shut unexpectedly. More than half would start looking elsewhere within a week. That is not a cute...

Continue Reading
Peñoles Locks In Solar Storage for Northern Mine Loads

Updated Category News Views 45

A mine never sleeps, which is why the battery matters more than the solar-panel headline. Peñoles has signed a 20-year power-supply agreement with Atlas Renewable Energy for a Coahuila project combining 269 MWp of solar generation with battery storage. The project is slated to begin operating in the first half of 2029 and is expected to provide roughly 550 GWh a year to...

Continue Reading
Norfolk Southern's 200-Year Campaign Meets a Hard Market

Updated Category News Views 61

Two centuries of railroad history can stir the blood, but it does not move a single carload by itself. Norfolk Southern has opened its 200-year railroading celebration with the GeneratioNS campaign, a three-locomotive NS 200 commemorative series, and plans for public events across its network. For a railroad with deep roots and very modern operational pressures, this is...

Continue Reading
Watson Motion Tests Military Pretrial Confinement Rules

Updated Category News Views 157

Military confinement fights are rarely neat, and this one comes with a short clock but plenty of unanswered questions. Defense lawyers for U.S. Air Force Maj. Jason Watson argued on Nov. 17 that he should be released from pretrial confinement while his case proceeds. A military judge is ordinarily expected to issue a ruling within 14 days of the hearing, under the court's...

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 90

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading

Top 5 Most Recently Viewed Articles

evolv Consulting and Snowflake Join Forces in Automotive Tech

Updated Category News Views 205

evolv Consulting Partners with Snowflake for Automotive Innovation evolv Consulting empowers data-driven insights at scale for the automotive industry through Snowflake AI Data Cloud for Manufacturing. evolv Consulting, recognized as an Elite Snowflake Services partner, has announced a strategic collaboration with Snowflake to enhance the AI Data Cloud for Manufacturing...

Continue Reading
Martela Corporation Shares Decline: Key Updates and Implications

Updated Category News Views 158

Martela Corporation Reports Notable Changes in Shareholding Martela Corporation has recently seen significant transactions that impact its share structure, which is crucial information for investors. On a particular date, Isku-Yhtymä Oy made an important announcement regarding its shareholding in Martela. This report revealed that Isku-Yhtymä Oy had sold enough shares...

Continue Reading
Forecasting Growth in the Chlorine Trifluoride Market by 2032

Updated Category News Views 221

Overview of the Chlorine Trifluoride Market Chlorine trifluoride is emerging as a pivotal player in numerous high-tech applications, with the market anticipated to reach a staggering USD 82.81 million by 2032. This significant growth is fueled by an annual compound growth rate (CAGR) of 4.64% from the previous years. The reactivity of chlorine trifluoride makes it an...

Continue Reading
Ryde Group's Public Offering: Key Insights and Developments

Updated Category News Views 274

Ryde Group Ltd (NYSE American: RYDE) made waves in the market with its public offering valued at approximately $4.5 million. The offering encompassed 5.3 million units, each comprising one Class A Ordinary Share plus a warrant that can be exercised into an additional Ordinary Share at $0.85. With warrants exercisable immediately and valid for five years, traders keen on...

Continue Reading
Citi's Optimistic Forecast for Enel Stock Amid Renewables Growth

Updated Category News Views 145

Citi's Optimistic Outlook on Enel Recently, Citi reaffirmed its strong Buy rating on Enel (BIT: ENEI) SpA stock, maintaining a price target of EUR7.40. This renewed confidence comes ahead of the company's anticipated third-quarter earnings announcement slated for early November. Analysts at Citi predict that Enel is poised to deliver robust financial results, prompting...

Continue Reading